GI
ALT icon

GAMMA Investing’s Altimmune ALT Stock Holding History

GAMMA Investing’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407 Buy
+134
New +$400 ﹤0.01% 4015
2025
Q3 		– Sell
-327
Closed -$1.26K – 3850
2025
Q2 		$1.26K Sell
327
-1,022
-76% -$5.53K ﹤0.01% 3492
2025
Q1 		$6.75K Sell
1,349
-798
-37% -$5.05K ﹤0.01% 2941
2024
Q4 		$15.5K Sell
2,147
-220
-9% -$1.68K ﹤0.01% 2395
2024
Q3 		$14.5K Sell
2,367
-852
-26% -$5.77K ﹤0.01% 2286
2024
Q2 		$21.4K Buy
3,219
+3,153
+4,777% +$23.3K ﹤0.01% 1809
2024
Q1 		$672 Buy
+66
New +$671 ﹤0.01% 3036

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAMMA Investing's ALT Position: Q2 2026 in Review

GAMMA Investing opened a new position in Altimmune (ALT) in Q2 2026: 134 shares worth $407. The stake represents ﹤0.01% of the portfolio and ranks #4015 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in ALT as recently as Q2 2025.

GAMMA Investing first reported a position in ALT in Q1 2024 and has held it in 7 quarters since. The position peaked at $21.4K in Q2 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • GAMMA Investing held 134 shares of Altimmune worth $407 as of Q2 2026.
  • Altimmune was a new GAMMA Investing position in Q2 2026.
  • Altimmune made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4015 holding.
  • GAMMA Investing first reported a position in Altimmune in Q1 2024 and has held it in 7 quarters since.
  • GAMMA Investing's Altimmune position peaked at $21.4K in Q2 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.